Medicare Enrolled
Dr. Swapna Goday, MD
Hematology & Oncology · Southlake, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Goday from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Goday?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Goday
Dr. Swapna Goday is a hematology & oncology specialist in Southlake, TX, with 14 years of NPI registration. Based on federal Medicare data, Dr. Goday performed 26,858 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Goday received a total of $20,055 from 42 pharmaceutical and/or device companies across 154 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Goday is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years of NPI registration
▲ Top 31% volume in TX
$20,055 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗26,858
Medicare services
Top 31% in TX for hematology & oncology
Not available
Unique patients (not deduplicated)
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
24,000 | $1 | $3 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
690 | $0 | $5 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
415 | $8 | $32 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
403 | $10 | $50 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
232 | $136 | $350 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
185 | $8 | $10 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
162 | $12 | $70 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
115 | $92 | $275 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
86 | $11 | $60 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
83 | $102 | $412 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
70 | $49 | $190 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
70 | $48 | $160 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
63 | $23 | $100 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
59 | $93 | $250 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
53 | $1 | $10 |
| New patient office visit, complex (60-74 min) | 42 | $157 | $500 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
34 | $135 | $500 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
28 | $41 | $175 |
| Additional 30 minutes of principal care management This service covers each additional 30 minutes of clinical staff time directed by a healthcare professional for managing a single high-risk disease, billed per calendar month. |
24 | $37 | $120 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
22 | $1,181 | $4,069 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 22 | $106 | $450 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
90.2% high complexity
3.8% medium
6.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$20,055
Total received (2018-2024)
Avg $2,865/year across 7 years
Top 21% in TX for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
154
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,717
2023
$2,920
2022
$298
2021
$73
2020
$388
2019
$20
2018
$14,640
Payments by company (2024)
BeiGene USA, Inc.
$675
AstraZeneca Pharmaceuticals LP
$186
GlaxoSmithKline, LLC.
$164
Blueprint Medicines Corporation
$145
Eisai Inc.
$88
Merck Sharp & Dohme LLC
$62
ABBVIE INC.
$58
Janssen Biotech, Inc.
$53
EMD Serono, Inc.
$37
SOBI, INC
$37
Alexion Pharmaceuticals, Inc.
$25
PFIZER INC.
$23
Geron Corporation
$23
Incyte Corporation
$22
Daiichi Sankyo Inc.
$21
Takeda Pharmaceuticals U.S.A., Inc.
$21
Lilly USA, LLC
$21
Gilead Sciences, Inc.
$19
Celgene Corporation
$18
E.R. Squibb & Sons, L.L.C.
$16
Top 3 companies account for 59.7% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$7,165
Janssen Pharmaceuticals, Inc
$6,847
GENZYME CORPORATION
$2,263
BeiGene USA, Inc.
$675
Janssen Biotech, Inc.
$303
AstraZeneca Pharmaceuticals LP
$249
E.R. Squibb & Sons, L.L.C.
$222
Celgene Corporation
$219
Daiichi Sankyo Inc.
$194
GlaxoSmithKline, LLC.
$186
Sirtex Medical Inc
$154
Novartis Pharmaceuticals Corporation
$149
Blueprint Medicines Corporation
$145
Merck Sharp & Dohme Corporation
$101
Eisai Inc.
$88
Regeneron Healthcare Solutions, Inc.
$87
ABBVIE INC.
$84
Lilly USA, LLC
$74
Myriad Genetic Laboratories, Inc.
$73
Merck Sharp & Dohme LLC
$62
Gilead Sciences, Inc.
$60
Incyte Corporation
$58
PFIZER INC.
$50
Takeda Pharmaceuticals U.S.A., Inc.
$49
Alexion Pharmaceuticals, Inc.
$45
Astellas Pharma US Inc
$45
MorphoSys, US Inc.
$43
EMD Serono, Inc.
$37
SOBI, INC
$37
CSL Behring
$34
AbbVie, Inc.
$34
Rigel Pharmaceuticals, Inc.
$33
Jazz Pharmaceuticals Inc.
$28
Geron Corporation
$23
Stemline Therapeutics Inc.
$20
Seagen Inc.
$19
Lexicon Pharmaceuticals, Inc.
$19
Tactile Systems Technology Inc
$16
Pharmacyclics LLC, An AbbVie Company
$16
PUMA BIOTECHNOLOGY, INC.
$16
Agios Pharmaceuticals, Inc.
$16
Genentech USA, Inc.
$14
Top 3 companies account for 81.2% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AYVAKIT · Abraxane · BOSULIF · BRUKINSA · CYRAMZA · DARZALEX · DOPTELET · EMPLICITI · ENHERTU · ERLEADA · EndoPredict · Enhertu · FLEXITOUCH · FRUZAQLA · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · Idelvion · Imbruvica · JADENU · JAKAFI · KANJINTI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LYNPARZA · Lenvima · MONJUVI · NERLYNX · NINLARO · NOXAFIL · Nplate · OJJAARA · OPDIVO · OPDUALAG · Orserdu · PADCEV · Padcev · Pomalyst · REBLOZYL · RYBREVANT · RYDAPT · RYTELO · Revlimid · SIR-Spheres Microspheres · SOLIRIS · TASIGNA · Tavalisse · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VYXEOS · Vectibix · Venclexta · XARELTO · XOSPATA · Xermelo · ZEJULA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
145
County median income
$81,905
Nearest hospital to ZIP centroid (approximate)
TEXAS HEALTH HARRIS METHODIST HOSPITAL SOUTHLAKE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Goday is a mixed practice specialist, with moderate Medicare volume.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Goday experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Goday performed 24,000 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Goday receive payments from pharmaceutical companies?
Yes. Dr. Goday received a total of $20,055 from 42 companies across 154 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Goday's costs compare to other hematology & oncology specialists in Southlake?
Dr. Goday's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Goday) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Southlake
Browse hematology & oncology specialists in Southlake ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in TX
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in TX
Which TX hematology & oncology specialists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology